$28.49
Today
as of Sep 4, 16:51 ET
Last 30 days
Recent Press Releases & News
Lakefront Gets FDA Orphan Drug Label for Gamgertamig
Lakefront Receives Transparency Notification from Bank of America
Morgan Stanley Adjusts PT on Lakefront Biotherapeutics to $26 From $30, Maintains Equalweight Rating
Overview
52-week range
$26
$38
23% of range
Avg surprise (last 2)
-427.1%
Avg reaction (last 2)
+1.6%
100% positive
Latest IV / EM
53%
EM ±10.4% · $30 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $0.25 | $-1.27 | +119.7% | +110.1% | +1.5% | earnings |
| Wed Apr 23, 2025 | Mar/2025 | $-2.47 | $-0.23 | -973.9% | — | +1.7% | earnings |